Penumbra Gross Margin 2014-2026 | PEN

Current and historical gross margin for Penumbra (PEN) over the last 10 years. The current gross profit margin for Penumbra as of June 30, 2026 is %.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Penumbra Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2026-06-30 $1.51B $1.02B 67.77%
2026-03-31 $1.45B $0.98B 67.33%
2025-12-31 $1.40B $0.94B 67.14%
2025-09-30 $1.33B $0.89B 66.79%
2025-06-30 $1.28B $0.85B 66.48%
2025-03-31 $1.24B $0.79B 63.71%
2024-12-31 $1.20B $0.76B 63.18%
2024-09-30 $1.16B $0.73B 62.80%
2024-06-30 $1.13B $0.71B 62.52%
2024-03-31 $1.10B $0.71B 65.05%
2023-12-31 $1.06B $0.68B 64.56%
2023-09-30 $0.99B $0.63B 63.78%
2023-06-30 $0.94B $0.59B 63.07%
2023-03-31 $0.88B $0.56B 63.12%
2022-12-31 $0.85B $0.53B 63.05%
2022-09-30 $0.83B $0.52B 62.77%
2022-06-30 $0.81B $0.51B 62.78%
2022-03-31 $0.78B $0.49B 62.79%
2021-12-31 $0.75B $0.48B 63.59%
2021-09-30 $0.71B $0.44B 62.54%
2021-06-30 $0.67B $0.42B 61.85%
2021-03-31 $0.59B $0.36B 60.98%
2020-12-31 $0.56B $0.34B 60.36%
2020-09-30 $0.54B $0.34B 63.57%
2020-06-30 $0.53B $0.35B 65.84%
2020-03-31 $0.56B $0.38B 67.63%
2019-12-31 $0.55B $0.37B 68.01%
2019-09-30 $0.52B $0.35B 67.50%
2019-06-30 $0.50B $0.33B 67.07%
2019-03-31 $0.47B $0.31B 65.82%
2018-12-31 $0.45B $0.29B 65.70%
2018-09-30 $0.42B $0.28B 66.03%
2018-06-30 $0.39B $0.26B 65.65%
2018-03-31 $0.36B $0.24B 65.11%
2017-12-31 $0.33B $0.22B 65.27%
2017-09-30 $0.31B $0.20B 64.63%
2017-06-30 $0.29B $0.19B 64.29%
2017-03-31 $0.28B $0.18B 64.39%
2016-12-31 $0.26B $0.17B 65.02%
2016-09-30 $0.24B $0.16B 65.57%
2016-06-30 $0.23B $0.15B 66.08%
2016-03-31 $0.20B $0.14B 66.67%
2015-12-31 $0.19B $0.12B 66.49%
2015-06-30 $0.11B $0.08B 66.37%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.599B $1.404B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.884B 25.75
Intuitive Surgical (ISRG) United States $133.518B 45.26
Edwards Lifesciences (EW) United States $49.242B 30.43
IQVIA Holdings (IQV) United States $43.729B 23.39
Waters (WAT) United States $40.283B 29.97
IDEXX Laboratories (IDXX) United States $40.144B 35.83
Alcon (ALC) Switzerland $33.505B 20.78
DexCom (DXCM) United States $31.955B 33.21
Mettler-Toledo (MTD) United States $25.762B 28.65
STERIS (STE) Ireland $20.832B 20.50
SONOVA HOLDING (SONVY) Switzerland $16.759B 0.00
Hologic (HOLX) United States $16.752B 17.53
Coloplast (CLPBY) Denmark $14.762B 17.70
Fresenius Medical Care AG KGaA (FMS) Germany $12.279B 8.59
Globus Medical (GMED) United States $10.173B 15.40
Glaukos (GKOS) United States $10.092B 0.00
Masimo (MASI) United States $9.578B 30.69
SARTORIUS (SSSGY) Germany $7.521B 43.67
Sysmex ADR (SSMXY) Japan $7.390B 27.95
Teleflex (TFX) United States $5.521B 14.89
LivaNova (LIVN) United Kingdom $4.442B 22.46
Integer Holdings (ITGR) United States $4.287B 19.86
Pulse Biosciences (PLSE) United States $3.752B 0.00
Veracyte (VCYT) United States $3.313B 27.11
TransMedics (TMDX) United States $2.967B 43.58
AxoGen (AXGN) United States $2.354B 0.00
UFP Technologies (UFPT) United States $2.153B 27.17
Elekta AB (EKTAY) Sweden $1.883B 17.62
Nihon Kohden (NHNKY) Japan $1.694B 15.52
Alphatec Holdings (ATEC) United States $1.677B 0.00
Alpha Tau Medical (DRTS) Israel $1.301B 0.00
Integra LifeSciences Holdings (IART) United States $1.222B 6.36
Artivion (AORT) United States $1.217B 46.24
PROCEPT BioRobotics (PRCT) United States $1.204B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.171B 27.77
Tandem Diabetes Care (TNDM) United States $1.170B 0.00
OPKO Health (OPK) United States $1.164B 0.00
IRadimed (IRMD) United States $1.055B 46.11
Anteris Technologies Global (AVR) Australia $0.850B 0.00
SiBone (SIBN) United States $0.829B 0.00
Beta Bionics (BBNX) United States $0.753B 0.00
Mesa Laboratories (MLAB) United States $0.680B 16.37
AngioDynamics (ANGO) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.583B 0.00
Delcath Systems (DCTH) United States $0.570B 1644.00
Tactile Systems Technology (TCMD) United States $0.511B 20.90
NeuroPace (NPCE) United States $0.501B 0.00
Sight Sciences (SGHT) United States $0.448B 0.00
Pacific Biosciences Of California (PACB) United States $0.420B 0.00
ClearPoint Neuro (CLPT) United States $0.411B 0.00
908 Devices (MASS) United States $0.402B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.371B 0.00
Mobia Medical (MOBI) United States $0.334B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Treace Medical Concepts (TMCI) United States $0.301B 0.00
Spectral Diagnostics (EDTXF) Canada $0.266B 0.00
RxSight (RXST) United States $0.254B 0.00
Neuronetics (STIM) United States $0.221B 0.00
Lucid Diagnostics (LUCD) United States $0.159B 0.00
FocalTherics (FOCL) France $0.154B 0.00
Inogen (INGN) United States $0.139B 0.00
EDAP TMS S.A (EDAP) France $0.124B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
LENSAR (LNSR) United States $0.096B 0.00
Hyperfine (HYPR) United States $0.085B 0.00
Zomedica (ZOMDF) United States $0.083B 0.00
CVRx (CVRX) United States $0.080B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
Covalon Technologies (CVALF) Canada $0.071B 23.27
DarioHealth (DRIO) United States $0.069B 0.00
Positron (POSC) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.059B 0.00
Envoy Medical (COCH) United States $0.056B 0.00
Nano-X Imaging (NNOX) Israel $0.055B 0.00
Spectral AI (MDAI) United States $0.052B 0.00
Sensus Healthcare (SRTS) United States $0.052B 0.00
Precision Optics (POCI) United States $0.048B 0.00
Baird Medical Investment Holdings (BDMD) $0.045B 0.00
InspireMD (NSPR) United States $0.038B 0.00
QT Imaging Holdings (QTI) United States $0.036B 0.00
PAVmed (PAVM) United States $0.035B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
Accuray (ARAY) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.004B 0.00
ENvue Medical (FEED) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
NexGel (NXGL) United States $0.003B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.000B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00